Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Olanzapine, sertindole and schizophrenia.

[No authors listed]

Drug Ther Bull. 1997 Nov;35(11):81-3. Review. No abstract available.

PMID:
9464002
2.

Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia.

Kasper S, Hale A, Azorin JM, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 2:II1-II14. No abstract available.

PMID:
10603070
3.

The new generation of antipsychotic drugs.

Tamminga CA, Lahti AC.

Int Clin Psychopharmacol. 1996 May;11 Suppl 2:73-6. Review.

PMID:
8803664
4.

Drug metabolism and atypical antipsychotics.

Prior TI, Chue PS, Tibbo P, Baker GB.

Eur Neuropsychopharmacol. 1999 Jun;9(4):301-9. Review.

PMID:
10422890
5.

New antipsychotic medications: strategies for evaluation and selected findings.

Schooler NR.

Schizophr Res. 1997 Oct 30;27(2-3):249-59. Review.

PMID:
9416654
6.

The promise of new drugs for schizophrenia treatment.

Tamminga CA.

Can J Psychiatry. 1997 Apr;42(3):265-73. Review.

PMID:
9114942
7.

Treatment of schizophrenia: advances during the decade of the brain.

Buckley PF.

Br J Hosp Med. 1996 Dec 11-1997 Jan 14;56(11):574-80. Review.

PMID:
8982483
8.

Sertindole versus haloperidol for schizophrenia.

Mattes JA.

Am J Psychiatry. 1998 Sep;155(9):1303; author reply 1303-4. No abstract available.

PMID:
9734567
9.

Sertindole versus haloperidol for schizophrenia.

Balon R.

Am J Psychiatry. 1998 Sep;155(9):1303-4. No abstract available.

PMID:
9734566
10.

Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics.

Borison RL.

J Clin Psychopharmacol. 1995 Feb;15(1 Suppl 1):24S-29S. Review.

PMID:
7537285
11.

The effectiveness of combining lithium with olanzapine in the treatment of resistant schizophrenia.

Martín JC, Palenciano G, Pérez R.

J Clin Psychiatry. 2000 Dec;61(12):948. No abstract available.

PMID:
11206602
12.

Atypical antipsychotics and cognition in schizophrenia.

Sharma T.

Arch Gen Psychiatry. 2002 Jun;59(6):571-2; author reply 573-5. No abstract available.

PMID:
12044209
13.

Novel antipsychotics: comparison of weight gain liabilities.

Wirshing DA, Wirshing WC, Kysar L, Berisford MA, Goldstein D, Pashdag J, Mintz J, Marder SR.

J Clin Psychiatry. 1999 Jun;60(6):358-63.

PMID:
10401912
14.

Clozapine to olanzapine.

Millson RC, Delva NJ.

Am J Psychiatry. 1999 Jul;156(7):1121. No abstract available.

PMID:
10401476
15.

High-dose olanzapine for treatment-refractory schizophrenia.

Sheitman BB, Lindgren JC, Early J, Sved M.

Am J Psychiatry. 1997 Nov;154(11):1626. No abstract available.

PMID:
9356581
16.

Sertindole for the treatment of schizophrenia.

Azorin JM, Kaladjian A, Fakra E, Adida M.

Expert Opin Pharmacother. 2010 Dec;11(18):3053-64. doi: 10.1517/14656566.2010.536217. Review.

PMID:
21080854
17.

New atypical antipsychotics. Experience and utility in the elderly.

Sweet RA, Pollock BG.

Drugs Aging. 1998 Feb;12(2):115-27. Review.

PMID:
9509290
18.

[New antipsychotic drugs].

Weizer M, Levy A, Davidson M.

Harefuah. 1997 Jul;133(1-2):57-60. Review. Hebrew. No abstract available.

PMID:
9332062
20.

Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety.

Tamminga CA, Mack RJ, Granneman GR, Silber CJ, Kashkin KB.

Int Clin Psychopharmacol. 1997 Feb;12 Suppl 1:S29-35. Review.

PMID:
9179641

Supplemental Content

Support Center